BCLSI
Bain Capital Life Sciences Investors’s Tango Therapeutics TNGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Hold |
2,712,008
| – | – | 1.74% | 13 |
|
|
2025
Q1 | $3.72M | Hold |
2,712,008
| – | – | 0.55% | 17 |
|
|
2024
Q4 | $8.38M | Hold |
2,712,008
| – | – | 0.99% | 15 |
|
|
2024
Q3 | $20.9M | Sell |
2,712,008
-180,655
| -6% | -$1.39M | 2.17% | 9 |
|
|
2024
Q2 | $24.8M | Hold |
2,892,663
| – | – | 2.72% | 9 |
|
|
2024
Q1 | $23M | Hold |
2,892,663
| – | – | 1.85% | 14 |
|
|
2023
Q4 | $28.6M | Hold |
2,892,663
| – | – | 2.75% | 10 |
|
|
2023
Q3 | $32.6M | Buy |
2,892,663
+970,873
| +51% | +$10.9M | 3.64% | 8 |
|
|
2023
Q2 | $6.38M | Hold |
1,921,790
| – | – | 0.66% | 27 |
|
|
2023
Q1 | $7.59M | Hold |
1,921,790
| – | – | 0.95% | 26 |
|
|
2022
Q4 | $13.9M | Hold |
1,921,790
| – | – | 1.56% | 18 |
|
|
2022
Q3 | $6.96M | Hold |
1,921,790
| – | – | 0.83% | 25 |
|
|
2022
Q2 | $8.71M | Hold |
1,921,790
| – | – | 1.02% | 20 |
|
|
2022
Q1 | $14.6M | Hold |
1,921,790
| – | – | 1.41% | 18 |
|
|
2021
Q4 | $21M | Hold |
1,921,790
| – | – | 1.67% | 16 |
|
|
2021
Q3 | $24.8M | Buy |
1,921,790
+1,000,000
| +108% | +$12.9M | 1.54% | 16 |
|
|
2021
Q2 | $10.5M | Buy |
921,790
+421,790
| +84% | +$4.8M | 0.69% | 22 |
|
|
2021
Q1 | $5.56M | Hold |
500,000
| – | – | 0.32% | 26 |
|
|
2020
Q4 | $5.72M | Hold |
500,000
| – | – | 0.36% | 22 |
|
|
2020
Q3 | $5.18M | Buy |
+500,000
| New | +$5.18M | 0.48% | 21 |
|